Notice Board

CANSA attended Symposium on the Impact of Nanotechnology on Cancer

CANSA attended Symposium on the Impact of Nanotechnology on Cancer

Dr Melissa Wallace, CANSA Head of Research at Symposium on the impact of nanotechnology on cancer

The South African Agency for Science and Technology Advancement (SAASTA) through the Nanotechnology Public Engagement Programme (NPEP), an initiative of the Department of Science and Technology (DST), and Nabio Consulting (Pty) Ltd presented a symposium on the impact of nanotechnology on cancer. The symposium was held on 25 October 2016 in Pretoria.

The aim of the symposium was to provide a platform for local researchers and industry to showcase ground-breaking academic and industrial research and promote development in the areas of cancer and nanotechnology.

Discussions at the symposium covered issues such as the cancer control programme of the WHO, cutting edge research in nanotechnology on cancer, intellectual property in publicly funded research, nanotoxicology, ethical aspects of nanotechnology and public-private partnership.

CANSA’s Head of Research, Dr Melissa Wallace attended the one day symposium to develop further understanding of the risks and benefits of this emerging field for cancer risk reduction and diagnostics.  She also gave a presentation on CANSA’s funding programme.


« BACK


Do you have a question?